Document is current

Article History

Received: 22 November 2023

Accepted: 17 September 2024

First Online: 12 October 2024

Declarations

:

: The MG DSP survey obtained ethics approval from the Western Institutional Review Board (sponsor protocol number: AG8768). Using a checkbox, patients provided informed consent to take part in the survey. Data were collected in such a way that patients and physicians could not be identified directly; all data were aggregated and de-identified before receipt. Data collection was undertaken in line with relevant legislation and guidelines including European Pharmaceutical Marketing Research Association guidelines [], the US Health Insurance Portability and Accountability Act 1996 [] and Health Information Technology for Economic and Clinical Health Act legislation [].

: Not required.

: JP and ZC are employees of Janssen Scientific Affairs, LLC. JdC, SB, GG, EC and SLB are employees of Adelphi Real World. RG is on the advisory board for Argenx, UCB and Janssen and serves as speaker for Argenx and Alexion. BH received payment as a contractor from Adelphi Real World for their involvement in this manuscript, and also receives payment as a contractor from Janssen (Pharmaceutical Companies of Johnson & Johnson), Amiculum Limited, and McCann Health Medical Communications.